)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Sandu Pharmaceuticals
Sandu Pharmaceuticals (524703) investor relations material
Sandu Pharmaceuticals Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary11 Aug, 2026
Executive summary
Unaudited standalone financial results for the quarter ended June 30, 2026, were approved, with the auditor expressing an unmodified conclusion on the review.
Directors' Report, Management Discussion and Analysis, and other annual reports for FY 2025-26 were approved for the upcoming AGM.
The 41st AGM is scheduled for September 11, 2026, via video conferencing.
Financial highlights
Revenue from operations for Q1 FY27 was ₹1,638.88 lakhs, compared to ₹1,669.90 lakhs in Q1 FY26 and ₹1,685.34 lakhs in Q4 FY26.
Profit before tax for Q1 FY27 was ₹36.05 lakhs, up from ₹33.87 lakhs in Q1 FY26 but down from ₹74.71 lakhs in Q4 FY26.
Net profit for Q1 FY27 stood at ₹22.82 lakhs, compared to ₹22.33 lakhs in Q1 FY26 and ₹4.34 lakhs in Q4 FY26.
Total comprehensive income for Q1 FY27 was ₹38.35 lakhs, versus ₹32.66 lakhs in Q1 FY26 and ₹70.68 lakhs in Q4 FY26.
Basic and diluted EPS for Q1 FY27 was ₹0.37, compared to ₹0.23 in Q1 FY26 and ₹0.04 in Q4 FY26.
Outlook and guidance
The Board approved the closure of the Register of Members and Share Transfer Books from September 4 to September 11, 2026, with September 4 as the record date for dividend eligibility.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sandu Pharmaceuticals
- FY26 saw higher revenue, profit, and cash, with a Rs. 1 dividend and no large borrowings.524703
Q4 25/26 - Q3 FY26 saw higher revenue and profit, with EPS at ₹1.01 and a single-segment focus.524703Q3 25/26
- Q2 FY26 saw higher revenue, improved profit, and robust cash flow in Ayurvedic medicines.524703Q2 25/26
- Q1 FY26 saw higher revenue and profit, with AGM and dividend record date set for September.524703Q1 25/26
- Revenue and profit grew modestly; subsidiary wound up; cash reserves increased.524703Q2 24/25
- Q1 FY25 saw revenue rise to ₹1,704.54 lakhs and a recommended dividend of ₹0.80 per share.524703Q1 24/25
- Stable financial performance with steady revenue, profit, and no new borrowings or equity changes.524703Q4 23/24
- FY25 saw steady profit growth, a dividend proposal, and a shift to standalone reporting.524703Q4 24/25
- Q3 FY25 net profit more than doubled year-over-year as Sandu shifts to standalone reporting.524703Q3 24/25
Next Sandu Pharmaceuticals earnings date
Q2 26/2711 Nov, 2026
Sandu Pharmaceuticals
Next Sandu Pharmaceuticals earnings date
Q2 26/2711 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage